Effects of Cholinesterase Inhibiting Sage ( ) on Mood, Anxiety and Performance on a Psychological Stressor Battery
Salvia officinalis (sage) has previously been shown both to possess in vitro cholinesterase inhibiting properties, and to enhance mnemonic performance and improve mood in healthy young participants. In this double-blind, placebo-controlled, crossover study, 30 healthy participants attended the labor...
Gespeichert in:
Veröffentlicht in: | Neuropsychopharmacology (New York, N.Y.) N.Y.), 2006-04, Vol.31 (4), p.845-852 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 852 |
---|---|
container_issue | 4 |
container_start_page | 845 |
container_title | Neuropsychopharmacology (New York, N.Y.) |
container_volume | 31 |
creator | KENNEDY, David O PACE, Sonia HASKELL, Crystal OKELLO, Edward J MILNE, Anthea SCHOLEY, Andrew B |
description | Salvia officinalis (sage) has previously been shown both to possess in vitro cholinesterase inhibiting properties, and to enhance mnemonic performance and improve mood in healthy young participants. In this double-blind, placebo-controlled, crossover study, 30 healthy participants attended the laboratory on three separate days, 7 days apart, receiving a different treatment in counterbalanced order on each occasion (placebo, 300, 600 mg dried sage leaf). On each day mood was assessed predose and at 1 and 4 h postdose. Each mood assessment comprised completion of Bond-Lader mood scales and the State Trait Anxiety Inventory (STAI) before and after 20 min performance of the Defined Intensity Stress Simulator (DISS) computerized multitasking battery. In a concomitant investigation, an extract of the sage leaf exhibited dose-dependent, in vitro inhibition of acetylcholinesterase and, to a greater extent, butyrylcholinesterase. Both doses of sage led to improved ratings of mood in the absence of the stressor (that is, in pre-DISS mood scores) postdose, with the lower dose reducing anxiety and the higher dose increasing 'alertness', 'calmness' and 'contentedness' on the Bond-Lader mood scales. The reduced anxiety effect following the lower dose was, however, abolished by performing the DISS, with the same dose also being associated with a reduction of alertness during performance. Task performance on the DISS battery was improved for the higher dose at both postdose sessions, but reduced for the lower dose at the later testing session. The results confirm previous observations of the cholinesterase inhibiting properties of S. officinalis, and improved mood and cognitive performance following the administration of single doses to healthy young participants. |
doi_str_mv | 10.1038/sj.npp.1300907 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67765060</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1012462251</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-933f840581194ae993fe3fe81e1b56edd81286324bb1f3d728b147440b80e3833</originalsourceid><addsrcrecordid>eNpd0c1r2zAYB2AxVta023W3DVFoWaHO9GVZPrah6wodK3SD3oRsv0oVHCmVbFj--yrEEBgIdHn00_uB0GdK5pRw9T2t5n6zmVNOSE2qd2hGK0EKycXzezQjquYF5fz5GJ2ktCKElpVUH9AxlYyUlSpnKN5aC-2QcLB48RJ65yENEE0CfO9fXOMG55f4ySwBf8OXOHj8K4TuCl_7fw6GLTa-w48QbYhr41vYAYMf07bNWWHpWtPjpyFCSiHiGzPk6O1HdGRNn-DTdJ-ivz9u_yx-Fg-_7-4X1w9FKygbippzqwQpFaW1MFDX3EI-igJtSgldpyhTkjPRNNTyrmKqoaISgjSKAFecn6KLfe4mhtcxt6XXLrXQ98ZDGJOWVSVLIkmGZ__BVRijz7VpxkrGhaxlRvM9amNIKYLVm-jWJm41JXq3Cp1WOq9CT6vID75OqWOzhu7Ap9lncD4Bk_KcbMwDdOngcnWUyV0fX_bOm2GMcADTR2-ucZq7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>225234696</pqid></control><display><type>article</type><title>Effects of Cholinesterase Inhibiting Sage ( ) on Mood, Anxiety and Performance on a Psychological Stressor Battery</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>KENNEDY, David O ; PACE, Sonia ; HASKELL, Crystal ; OKELLO, Edward J ; MILNE, Anthea ; SCHOLEY, Andrew B</creator><creatorcontrib>KENNEDY, David O ; PACE, Sonia ; HASKELL, Crystal ; OKELLO, Edward J ; MILNE, Anthea ; SCHOLEY, Andrew B</creatorcontrib><description>Salvia officinalis (sage) has previously been shown both to possess in vitro cholinesterase inhibiting properties, and to enhance mnemonic performance and improve mood in healthy young participants. In this double-blind, placebo-controlled, crossover study, 30 healthy participants attended the laboratory on three separate days, 7 days apart, receiving a different treatment in counterbalanced order on each occasion (placebo, 300, 600 mg dried sage leaf). On each day mood was assessed predose and at 1 and 4 h postdose. Each mood assessment comprised completion of Bond-Lader mood scales and the State Trait Anxiety Inventory (STAI) before and after 20 min performance of the Defined Intensity Stress Simulator (DISS) computerized multitasking battery. In a concomitant investigation, an extract of the sage leaf exhibited dose-dependent, in vitro inhibition of acetylcholinesterase and, to a greater extent, butyrylcholinesterase. Both doses of sage led to improved ratings of mood in the absence of the stressor (that is, in pre-DISS mood scores) postdose, with the lower dose reducing anxiety and the higher dose increasing 'alertness', 'calmness' and 'contentedness' on the Bond-Lader mood scales. The reduced anxiety effect following the lower dose was, however, abolished by performing the DISS, with the same dose also being associated with a reduction of alertness during performance. Task performance on the DISS battery was improved for the higher dose at both postdose sessions, but reduced for the lower dose at the later testing session. The results confirm previous observations of the cholinesterase inhibiting properties of S. officinalis, and improved mood and cognitive performance following the administration of single doses to healthy young participants.</description><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/sj.npp.1300907</identifier><identifier>PMID: 16205785</identifier><identifier>CODEN: NEROEW</identifier><language>eng</language><publisher>New York, NY: Nature Publishing</publisher><subject>Adult ; Affect - drug effects ; Analysis of Variance ; Anxiety ; Anxiety - drug therapy ; Biological and medical sciences ; Cholinesterase Inhibitors - isolation & purification ; Cholinesterase Inhibitors - pharmacology ; Cholinesterase Inhibitors - therapeutic use ; Cholinesterases - metabolism ; Cross-Over Studies ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Humans ; Male ; Mathematics ; Medical sciences ; Neuropharmacology ; Personality Inventory - statistics & numerical data ; Pharmacology. Drug treatments ; Psycholeptics: tranquillizer, neuroleptic ; Psychological Tests - statistics & numerical data ; Psychology. Psychoanalysis. Psychiatry ; Psychomotor Performance - drug effects ; Psychopharmacology ; Salvia officinalis - chemistry ; Stress, Psychological - drug therapy ; Time Factors ; Treatment Outcome</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2006-04, Vol.31 (4), p.845-852</ispartof><rights>2006 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Apr 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-933f840581194ae993fe3fe81e1b56edd81286324bb1f3d728b147440b80e3833</citedby><cites>FETCH-LOGICAL-c412t-933f840581194ae993fe3fe81e1b56edd81286324bb1f3d728b147440b80e3833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17651263$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16205785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KENNEDY, David O</creatorcontrib><creatorcontrib>PACE, Sonia</creatorcontrib><creatorcontrib>HASKELL, Crystal</creatorcontrib><creatorcontrib>OKELLO, Edward J</creatorcontrib><creatorcontrib>MILNE, Anthea</creatorcontrib><creatorcontrib>SCHOLEY, Andrew B</creatorcontrib><title>Effects of Cholinesterase Inhibiting Sage ( ) on Mood, Anxiety and Performance on a Psychological Stressor Battery</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacology</addtitle><description>Salvia officinalis (sage) has previously been shown both to possess in vitro cholinesterase inhibiting properties, and to enhance mnemonic performance and improve mood in healthy young participants. In this double-blind, placebo-controlled, crossover study, 30 healthy participants attended the laboratory on three separate days, 7 days apart, receiving a different treatment in counterbalanced order on each occasion (placebo, 300, 600 mg dried sage leaf). On each day mood was assessed predose and at 1 and 4 h postdose. Each mood assessment comprised completion of Bond-Lader mood scales and the State Trait Anxiety Inventory (STAI) before and after 20 min performance of the Defined Intensity Stress Simulator (DISS) computerized multitasking battery. In a concomitant investigation, an extract of the sage leaf exhibited dose-dependent, in vitro inhibition of acetylcholinesterase and, to a greater extent, butyrylcholinesterase. Both doses of sage led to improved ratings of mood in the absence of the stressor (that is, in pre-DISS mood scores) postdose, with the lower dose reducing anxiety and the higher dose increasing 'alertness', 'calmness' and 'contentedness' on the Bond-Lader mood scales. The reduced anxiety effect following the lower dose was, however, abolished by performing the DISS, with the same dose also being associated with a reduction of alertness during performance. Task performance on the DISS battery was improved for the higher dose at both postdose sessions, but reduced for the lower dose at the later testing session. The results confirm previous observations of the cholinesterase inhibiting properties of S. officinalis, and improved mood and cognitive performance following the administration of single doses to healthy young participants.</description><subject>Adult</subject><subject>Affect - drug effects</subject><subject>Analysis of Variance</subject><subject>Anxiety</subject><subject>Anxiety - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Cholinesterase Inhibitors - isolation & purification</subject><subject>Cholinesterase Inhibitors - pharmacology</subject><subject>Cholinesterase Inhibitors - therapeutic use</subject><subject>Cholinesterases - metabolism</subject><subject>Cross-Over Studies</subject><subject>Dose-Response Relationship, Drug</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Mathematics</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Personality Inventory - statistics & numerical data</subject><subject>Pharmacology. Drug treatments</subject><subject>Psycholeptics: tranquillizer, neuroleptic</subject><subject>Psychological Tests - statistics & numerical data</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychomotor Performance - drug effects</subject><subject>Psychopharmacology</subject><subject>Salvia officinalis - chemistry</subject><subject>Stress, Psychological - drug therapy</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpd0c1r2zAYB2AxVta023W3DVFoWaHO9GVZPrah6wodK3SD3oRsv0oVHCmVbFj--yrEEBgIdHn00_uB0GdK5pRw9T2t5n6zmVNOSE2qd2hGK0EKycXzezQjquYF5fz5GJ2ktCKElpVUH9AxlYyUlSpnKN5aC-2QcLB48RJ65yENEE0CfO9fXOMG55f4ySwBf8OXOHj8K4TuCl_7fw6GLTa-w48QbYhr41vYAYMf07bNWWHpWtPjpyFCSiHiGzPk6O1HdGRNn-DTdJ-ivz9u_yx-Fg-_7-4X1w9FKygbippzqwQpFaW1MFDX3EI-igJtSgldpyhTkjPRNNTyrmKqoaISgjSKAFecn6KLfe4mhtcxt6XXLrXQ98ZDGJOWVSVLIkmGZ__BVRijz7VpxkrGhaxlRvM9amNIKYLVm-jWJm41JXq3Cp1WOq9CT6vID75OqWOzhu7Ap9lncD4Bk_KcbMwDdOngcnWUyV0fX_bOm2GMcADTR2-ucZq7</recordid><startdate>20060401</startdate><enddate>20060401</enddate><creator>KENNEDY, David O</creator><creator>PACE, Sonia</creator><creator>HASKELL, Crystal</creator><creator>OKELLO, Edward J</creator><creator>MILNE, Anthea</creator><creator>SCHOLEY, Andrew B</creator><general>Nature Publishing</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20060401</creationdate><title>Effects of Cholinesterase Inhibiting Sage ( ) on Mood, Anxiety and Performance on a Psychological Stressor Battery</title><author>KENNEDY, David O ; PACE, Sonia ; HASKELL, Crystal ; OKELLO, Edward J ; MILNE, Anthea ; SCHOLEY, Andrew B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-933f840581194ae993fe3fe81e1b56edd81286324bb1f3d728b147440b80e3833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Affect - drug effects</topic><topic>Analysis of Variance</topic><topic>Anxiety</topic><topic>Anxiety - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Cholinesterase Inhibitors - isolation & purification</topic><topic>Cholinesterase Inhibitors - pharmacology</topic><topic>Cholinesterase Inhibitors - therapeutic use</topic><topic>Cholinesterases - metabolism</topic><topic>Cross-Over Studies</topic><topic>Dose-Response Relationship, Drug</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Mathematics</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Personality Inventory - statistics & numerical data</topic><topic>Pharmacology. Drug treatments</topic><topic>Psycholeptics: tranquillizer, neuroleptic</topic><topic>Psychological Tests - statistics & numerical data</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychomotor Performance - drug effects</topic><topic>Psychopharmacology</topic><topic>Salvia officinalis - chemistry</topic><topic>Stress, Psychological - drug therapy</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KENNEDY, David O</creatorcontrib><creatorcontrib>PACE, Sonia</creatorcontrib><creatorcontrib>HASKELL, Crystal</creatorcontrib><creatorcontrib>OKELLO, Edward J</creatorcontrib><creatorcontrib>MILNE, Anthea</creatorcontrib><creatorcontrib>SCHOLEY, Andrew B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KENNEDY, David O</au><au>PACE, Sonia</au><au>HASKELL, Crystal</au><au>OKELLO, Edward J</au><au>MILNE, Anthea</au><au>SCHOLEY, Andrew B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Cholinesterase Inhibiting Sage ( ) on Mood, Anxiety and Performance on a Psychological Stressor Battery</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><addtitle>Neuropsychopharmacology</addtitle><date>2006-04-01</date><risdate>2006</risdate><volume>31</volume><issue>4</issue><spage>845</spage><epage>852</epage><pages>845-852</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><coden>NEROEW</coden><abstract>Salvia officinalis (sage) has previously been shown both to possess in vitro cholinesterase inhibiting properties, and to enhance mnemonic performance and improve mood in healthy young participants. In this double-blind, placebo-controlled, crossover study, 30 healthy participants attended the laboratory on three separate days, 7 days apart, receiving a different treatment in counterbalanced order on each occasion (placebo, 300, 600 mg dried sage leaf). On each day mood was assessed predose and at 1 and 4 h postdose. Each mood assessment comprised completion of Bond-Lader mood scales and the State Trait Anxiety Inventory (STAI) before and after 20 min performance of the Defined Intensity Stress Simulator (DISS) computerized multitasking battery. In a concomitant investigation, an extract of the sage leaf exhibited dose-dependent, in vitro inhibition of acetylcholinesterase and, to a greater extent, butyrylcholinesterase. Both doses of sage led to improved ratings of mood in the absence of the stressor (that is, in pre-DISS mood scores) postdose, with the lower dose reducing anxiety and the higher dose increasing 'alertness', 'calmness' and 'contentedness' on the Bond-Lader mood scales. The reduced anxiety effect following the lower dose was, however, abolished by performing the DISS, with the same dose also being associated with a reduction of alertness during performance. Task performance on the DISS battery was improved for the higher dose at both postdose sessions, but reduced for the lower dose at the later testing session. The results confirm previous observations of the cholinesterase inhibiting properties of S. officinalis, and improved mood and cognitive performance following the administration of single doses to healthy young participants.</abstract><cop>New York, NY</cop><pub>Nature Publishing</pub><pmid>16205785</pmid><doi>10.1038/sj.npp.1300907</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0893-133X |
ispartof | Neuropsychopharmacology (New York, N.Y.), 2006-04, Vol.31 (4), p.845-852 |
issn | 0893-133X 1740-634X |
language | eng |
recordid | cdi_proquest_miscellaneous_67765060 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Adult Affect - drug effects Analysis of Variance Anxiety Anxiety - drug therapy Biological and medical sciences Cholinesterase Inhibitors - isolation & purification Cholinesterase Inhibitors - pharmacology Cholinesterase Inhibitors - therapeutic use Cholinesterases - metabolism Cross-Over Studies Dose-Response Relationship, Drug Double-Blind Method Female Humans Male Mathematics Medical sciences Neuropharmacology Personality Inventory - statistics & numerical data Pharmacology. Drug treatments Psycholeptics: tranquillizer, neuroleptic Psychological Tests - statistics & numerical data Psychology. Psychoanalysis. Psychiatry Psychomotor Performance - drug effects Psychopharmacology Salvia officinalis - chemistry Stress, Psychological - drug therapy Time Factors Treatment Outcome |
title | Effects of Cholinesterase Inhibiting Sage ( ) on Mood, Anxiety and Performance on a Psychological Stressor Battery |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A13%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Cholinesterase%20Inhibiting%20Sage%20(%20)%20on%20Mood,%20Anxiety%20and%20Performance%20on%20a%20Psychological%20Stressor%20Battery&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=KENNEDY,%20David%20O&rft.date=2006-04-01&rft.volume=31&rft.issue=4&rft.spage=845&rft.epage=852&rft.pages=845-852&rft.issn=0893-133X&rft.eissn=1740-634X&rft.coden=NEROEW&rft_id=info:doi/10.1038/sj.npp.1300907&rft_dat=%3Cproquest_cross%3E1012462251%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=225234696&rft_id=info:pmid/16205785&rfr_iscdi=true |